Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset.

Witas R, Peck AB, Ambrus JL, Nguyen CQ.

J Immunol Res. 2019 May 13;2019:4813795. doi: 10.1155/2019/4813795. eCollection 2019. Review.

2.

Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment.

Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, Shafer B, Peck A, Sivils K, Rasmussen A, Chiorini JA, He J, Ambrus JL Jr.

Clin Immunol. 2019 Jun;203:81-121. doi: 10.1016/j.clim.2019.04.009. Epub 2019 Apr 29. Review. No abstract available.

PMID:
31022578
3.

Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus - a prospective cohort study.

Zhang RJ, Zhang X, Chen J, Shao M, Yang Y, Balaubramaniam B, Sun XL, Ambrus JL Jr, He J, Li ZG.

Lupus. 2018 Jun;27(7):1100-1106. doi: 10.1177/0961203318760993. Epub 2018 Feb 26.

PMID:
29482443
4.

P2Y2 R deletion ameliorates sialadenitis in IL-14α-transgenic mice.

Woods LT, Camden JM, Khalafalla MG, Petris MJ, Erb L, Ambrus JL Jr, Weisman GA.

Oral Dis. 2018 Jul;24(5):761-771. doi: 10.1111/odi.12823. Epub 2018 Mar 13.

5.

Sjogren's syndrome: New paradigms and areas for future research.

Ambrus JL Jr.

Clin Immunol. 2017 Sep;182:1-3. doi: 10.1016/j.clim.2017.06.011. Epub 2017 Jun 30. No abstract available.

PMID:
28673862
6.

Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren's Syndrome.

De Langhe E, Bossuyt X, Shen L, Malyavantham K, Ambrus JL, Suresh L.

Open Rheumatol J. 2017 Jan 31;11:10-15. doi: 10.2174/1874312901711010010. eCollection 2017.

7.

The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.

Beckman KA, Luchs J, Milner MS, Ambrus JL Jr.

Adv Ther. 2017 Apr;34(4):799-812. doi: 10.1007/s12325-017-0501-3. Epub 2017 Mar 10. Review.

PMID:
28283891
8.

Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.

Everett S, Vishwanath S, Cavero V, Shen L, Suresh L, Malyavantham K, Lincoff-Cohen N, Ambrus JL Jr.

BMC Ophthalmol. 2017 Mar 7;17(1):20. doi: 10.1186/s12886-017-0412-8.

9.

Multiple Roles for B-Lymphocytes in Sjogren's Syndrome.

Ambrus JL, Suresh L, Peck A.

J Clin Med. 2016 Oct 8;5(10). pii: E87. Review.

10.

Central role for marginal zone B cells in an animal model of Sjogren's syndrome.

Shen L, Gao C, Suresh L, Xian Z, Song N, Chaves LD, Yu M, Ambrus JL Jr.

Clin Immunol. 2016 Jul;168:30-36. doi: 10.1016/j.clim.2016.04.008. Epub 2016 Apr 30.

11.

Gastrointestinal disease in Sjogren's syndrome: related to food hypersensitivities.

Kim-Lee C, Suresh L, Ambrus JL Jr.

Springerplus. 2015 Dec 12;4:766. doi: 10.1186/s40064-015-1557-7. eCollection 2015.

12.

Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.

Sternberg Z, Chichelli T, Sternberg D, Sawyer R, Ching M, Janicke D, Ambrus JL, Yu J, Munschauer F.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):327-34. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.001. Epub 2015 Nov 12.

PMID:
26586373
13.

Inflammatory Joint Diseases.

Shi G, Ambrus JL, Ye S, Shen L.

Biomed Res Int. 2015;2015:973510. doi: 10.1155/2015/973510. Epub 2015 May 21. No abstract available.

14.

Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.

Suresh L, Malyavantham K, Shen L, Ambrus JL Jr.

BMC Ophthalmol. 2015 Apr 10;15:38. doi: 10.1186/s12886-015-0023-1.

15.

Update on the use of biologics in vasculitides.

Vishwanath S, Relan M, Shen L, Ambrus JL Jr.

Curr Pharm Biotechnol. 2014;15(6):558-62. Review.

PMID:
25213365
16.

Biologics in systemic sclerosis.

Xuan J, Shen L, Zhang C, Ambrus JL Jr.

Curr Pharm Biotechnol. 2014;15(6):549-57. Review.

PMID:
25213364
17.

Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome.

Shen L, Kapsogeorgou EK, Yu M, Suresh L, Malyavantham K, Tzioufas AG, Ambrus JL Jr.

Clin Immunol. 2014 Nov;155(1):42-6. doi: 10.1016/j.clim.2014.08.009. Epub 2014 Aug 30.

PMID:
25178982
18.

Update on the use of biologics in lupus.

Relan M, Vishwanath S, Shen L, Ambrus JL Jr.

Curr Pharm Biotechnol. 2014;15(6):516-20. Review.

PMID:
25091119
19.

Xerophthalmia of Sjogren's Syndrome Diagnosed with Anti-Salivary Gland Protein 1 Antibodies.

Vishwanath S, Everett S, Shen L, Malyavantham K, Suresh L, Ambrus JL Jr.

Case Rep Ophthalmol. 2014 Jun 28;5(2):186-9. doi: 10.1159/000364941. eCollection 2014 May.

20.

Anti-salivary gland protein 1 antibodies in two patients with Sjogren's syndrome: two case reports.

Vishwanath S, Shen L, Suresh L, Ambrus JL Jr.

J Med Case Rep. 2014 May 11;8:145. doi: 10.1186/1752-1947-8-145.

21.

Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature.

Gupta S, Zivadinov R, Ramasamy D, Ambrus JL Jr.

Clin Rheumatol. 2014 Dec;33(12):1829-33. doi: 10.1007/s10067-013-2434-9. Epub 2013 Nov 26. Review.

PMID:
24277114
22.

Oral contraceptives, ABO blood types and thromboembolism.

Ambrus JL.

CMAJ. 2013 Nov 19;185(17):1526. doi: 10.1503/cmaj.113-2148. No abstract available.

23.

Temporal histological changes in lacrimal and major salivary glands in mouse models of Sjogren's syndrome.

Xuan J, Shen L, Malyavantham K, Pankewycz O, Ambrus JL Jr, Suresh L.

BMC Oral Health. 2013 Oct 5;13:51. doi: 10.1186/1472-6831-13-51.

24.

Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood.

Sternberg Z, Ghanim H, Gillotti KM, Tario JD Jr, Munschauer F, Curl R, Noor S, Yu J, Ambrus JL Sr, Wallace P, Dandona P.

Atherosclerosis. 2013 Aug;229(2):338-47. doi: 10.1016/j.atherosclerosis.2013.04.035. Epub 2013 May 14.

PMID:
23880185
25.

Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN.

Shen L, Suresh L, Malyavantham K, Kowal P, Xuan J, Lindemann MJ, Ambrus JL Jr.

J Immunol. 2013 Jul 15;191(2):608-13. doi: 10.4049/jimmunol.1203440. Epub 2013 Jun 14.

26.

Novel autoantibodies in Sjogren's syndrome.

Shen L, Suresh L, Lindemann M, Xuan J, Kowal P, Malyavantham K, Ambrus JL Jr.

Clin Immunol. 2012 Dec;145(3):251-5. doi: 10.1016/j.clim.2012.09.013. Epub 2012 Oct 12.

PMID:
23123440
27.

Mitochondrial myopathy presenting as fibromyalgia: a case report.

Abdullah M, Vishwanath S, Elbalkhi A, Ambrus JL Jr.

J Med Case Rep. 2012 Feb 10;6:55. doi: 10.1186/1752-1947-6-55.

28.

Metabolic myopathy presenting with polyarteritis nodosa: a case report.

Vishwanath S, Abdullah M, Elbalkhi A, Ambrus JL Jr.

J Med Case Rep. 2011 Jun 30;5:262. doi: 10.1186/1752-1947-5-262.

29.

A role for lymphotoxin in primary Sjogren's disease.

Shen L, Suresh L, Wu J, Xuan J, Li H, Zhang C, Pankewycz O, Ambrus JL Jr.

J Immunol. 2010 Nov 15;185(10):6355-63. doi: 10.4049/jimmunol.1001520. Epub 2010 Oct 15.

30.

Bortezomib plus melphalan and prednisone for multiple myeloma.

Islam A, Ambrus JL.

N Engl J Med. 2008 Dec 11;359(24):2613; author reply 2613-4. doi: 10.1056/NEJMc086420. No abstract available.

PMID:
19073984
31.

IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.

Shen L, Suresh L, Li H, Zhang C, Kumar V, Pankewycz O, Ambrus JL Jr.

Clin Immunol. 2009 Mar;130(3):304-12. doi: 10.1016/j.clim.2008.10.006. Epub 2008 Nov 26.

PMID:
19038581
32.

Bioterror, agroterror, and new diseases.

Ambrus JL Sr, Ambrus CM, Ambrus JL Jr, Akhter S, Zaidi S, Rohilla R, Baig MS.

Discov Med. 2007 Jun;7(38):82-7.

33.

YABA virus induced tumor in men--long term follow-up and possible bio-warfare role.

Ambrus JL, Ambrus CM.

J Med. 2004;35(1-6):277-9. No abstract available.

PMID:
18084885
34.

Breast cancer in intraductal carcinogen-treated non-human primates.

Lillie MA, Ambrus CM, Pickren JW, Akhter S, Islam A, Ambrus JL.

J Med. 2004;35(1-6):271-5.

PMID:
18084884
35.

Multiple medical problems following agent orange exposure.

Ambrus JL, Islam A, Akhter S, Dembinski W, Kulaylat M, Ambrus CM.

J Med. 2004;35(1-6):265-9.

PMID:
18084883
36.

New approaches to the treatment of AIDS with special reference to overcoming interferon resistance.

Ambrus JL Sr, Ambrus JL Jr, Bardos TJ, Dembinski W, Chadha KC.

J Med. 2004;35(1-6):201-9. Review.

PMID:
18084878
37.

Studies on the radioprotective effect of etiocholanolone.

Ambrus JL, Ambrus CM, Gahwyler ME, Akhter S, Jankowski A, Lane W.

J Med. 2004;35(1-6):75-86.

PMID:
18084866
38.

Studies on splenic population size feedback control regulatory mechanisms.

Ambrus CM, Sykes DE, Kulaylat MN, Akhter S, Lane W, Ambrus JL Sr.

J Med. 2004;35(1-6):27-31.

PMID:
18084862
39.

Hemophilia D factor (factor XII), red-cell deformability and platelet aggregates in raptors.

Ambrus JL, Ambrus CM, Robin JC.

J Med. 2004;35(1-6):19-25.

PMID:
18084861
40.

Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.

Ambrus CM, Stadler I, Toumbis CA, Stadler A, Anthone S, Anthone R, DeAlarcon P, Deshpande G, Conway J, Vladutiu AO, Ambrus JL Jr.

J Med. 1999;30(3-4):211-24.

PMID:
17312675
41.

Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.

Ambrus CM, Lajos TZ, Stadler I, Stadler A, Alfano J, Tulumello JA, Ambrus JL Jr.

J Med. 1999;30(3-4):157-67.

PMID:
17312669
42.

Development of a murine model for blastoid variant mantle-cell lymphoma.

Ford RJ, Shen L, Lin-Lee YC, Pham LV, Multani A, Zhou HJ, Tamayo AT, Zhang C, Hawthorn L, Cowell JK, Ambrus JL Jr.

Blood. 2007 Jun 1;109(11):4899-906. Epub 2007 Feb 20.

43.

Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products.

Ludwig LB, Ambrus JL Jr, Krawczyk KA, Sharma S, Brooks S, Hsiao CB, Schwartz SA.

Retrovirology. 2006 Nov 8;3:80.

44.

Development of autoimmunity in IL-14alpha-transgenic mice.

Shen L, Zhang C, Wang T, Brooks S, Ford RJ, Lin-Lee YC, Kasianowicz A, Kumar V, Martin L, Liang P, Cowell J, Ambrus JL Jr.

J Immunol. 2006 Oct 15;177(8):5676-86.

45.

Treatment of viral and neoplastic diseases with double-stranded RNA derivatives and other new agents.

Ambrus JL Sr, Chadha KC, Islam A, Akhter S, Ambrus JL Jr.

Exp Biol Med (Maywood). 2006 Sep;231(8):1283-6. Review.

PMID:
16946396
46.

Progressive cerebral disease in lymphomatoid granulomatosis causes anterograde amnesia and neuropsychiatric disorder.

Carone DA, Benedict RH, Zivadinov R, Singh B, Ambrus JL.

J Neuroimaging. 2006 Apr;16(2):163-6.

PMID:
16629740
47.

Attempts to induce differentiation of neoplastic cells to normal.

Ambrus JL, Ambrus CM, Akhtar S, Srivastava M.

Discov Med. 2005 Aug;5(28):403-6.

48.

Therapy of newly emerging mutant viral disorders and role in bioterrorism.

Ambrus JL Sr, Ambrus JL Jr, Ambrus CM.

Med Hypotheses. 2005;64(6):1248-9. No abstract available.

PMID:
15823736
49.

Silencing of human c-myc oncogene expression by poly-DNP-RNA.

Shen L, Zhang C, Ambrus JL, Wang JH.

Oligonucleotides. 2005 Spring;15(1):23-35.

PMID:
15788898
50.

Supplemental Content

Loading ...
Support Center